Inavolisib

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C18H19F2N5O4
Molecular Weight	407.3714
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@H](NC1=CC=C2C3=NC(=CN3CCOC2=C1)N4[C@@H](COC4=O)C(F)F)C(N)=O

InChI

InChIKey=SGEUNORSOZVTOL-CABZTGNLSA-N

InChI=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11)24)25-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26)/t9-,12-/m0/s1

HIDE SMILES / InChI

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
PI3-kinase p110-alpha subunit 41 Target ID: CHEMBL4005 Sources: http://cancerres.aacrjournals.org/content/77/13_Supplement/156	Inhibitor 8504		0.038 nM [IC50]

Name

Type

Language

Inavolisib

Official Name

English

inavolisib [INN]

Preferred Name

English

RG6114

Code

English

Inavolisib [WHO-DD]

Common Name

English

RO7113755

Code

English

RO-7113755

Code

English

GDC-0077

Code

English

(2S)-2-({2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)propanamide

Systematic Name

English

INAVOLISIB [USAN]

Common Name

English

ITOVEBI

Brand Name

English

Propanamide, 2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]-, (2S)-

Systematic Name

English

RG-6114

Code

English

(2S)-2-[[2-[(4S)-4-(Difluoromethyl)-2-oxo-3-oxazolidinyl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide

Systematic Name

English

GDC0077

Code

English

Code System Code Type Description

USAN

HI-206